Dianthus Therapeutics | MGTA - Capital Social Ordinario

Precio De Mercado
88.09
Cambio Diario
0.29 0.33%
Mensual
2.43%
Anual
305.76%
Q2 Expectativa
85.52




Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
IQVIA Holdings USD 169.6M 700K 2025-12
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Moderna USD 391M 2M 2025-09
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Organon & Co USD 260.32M 333K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pharma Mar EUR 17.36M 214.99K 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03